| Wal Mart Pharmacy 10-5397 | |
| 955 Frontenac Dr, Winona, Minnesota 55987 | |
| (507) 452-0615 |
| Name | Wal Mart Pharmacy 10-5397 |
|---|---|
| Organization Name | Walmart Inc |
| Location | 955 Frontenac Dr, Winona, Minnesota 55987 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (507) 452-0615 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers from UCLA's Jonsson Comprehensive Cancer Center (JCCC) have discovered that specific types of bacteria that live in the gut are major contributors to lymphoma, a cancer of the white blood cells that are part of the human immune system.
Idera Pharmaceuticals, Inc. today presented data on the mechanism of action of IMO-3100, an antagonist of Toll-like Receptor (TLR) 7 and TLR9, in a preclinical primate model at the Keystone Symposia conference "Tolerance and Autoimmunity" being held February 21-26 in Taos, New Mexico. Idera is developing IMO-3100 for the treatment of autoimmune diseases. The presentation entitled "IMO-3100, a novel antagonist, suppresses TLR7- and TLR9-mediated immune responses in non-human primates" was made by Idera scientists.
During a recent three-day Asian Vaccine Conference, health experts appealed to countries to add "under-utilised vaccines such as those of pneumococcal, haemophilus influenzae type-b (Hib), and rotavirus" into national immunization programs, the Nation reports.
Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial.
› Verified 6 days ago
| NPI Number | 1083631485 |
| Organization Name | WALMART INC. |
| Doing Business As | WALMART PHARMACY 10-5397 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 955 Frontenac Dr, Winona, MN 55987 |
| Phone Number | 507-452-0615 |
News Archive
Researchers from UCLA's Jonsson Comprehensive Cancer Center (JCCC) have discovered that specific types of bacteria that live in the gut are major contributors to lymphoma, a cancer of the white blood cells that are part of the human immune system.
Idera Pharmaceuticals, Inc. today presented data on the mechanism of action of IMO-3100, an antagonist of Toll-like Receptor (TLR) 7 and TLR9, in a preclinical primate model at the Keystone Symposia conference "Tolerance and Autoimmunity" being held February 21-26 in Taos, New Mexico. Idera is developing IMO-3100 for the treatment of autoimmune diseases. The presentation entitled "IMO-3100, a novel antagonist, suppresses TLR7- and TLR9-mediated immune responses in non-human primates" was made by Idera scientists.
During a recent three-day Asian Vaccine Conference, health experts appealed to countries to add "under-utilised vaccines such as those of pneumococcal, haemophilus influenzae type-b (Hib), and rotavirus" into national immunization programs, the Nation reports.
Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial.
› Verified 6 days ago
News Archive
Researchers from UCLA's Jonsson Comprehensive Cancer Center (JCCC) have discovered that specific types of bacteria that live in the gut are major contributors to lymphoma, a cancer of the white blood cells that are part of the human immune system.
Idera Pharmaceuticals, Inc. today presented data on the mechanism of action of IMO-3100, an antagonist of Toll-like Receptor (TLR) 7 and TLR9, in a preclinical primate model at the Keystone Symposia conference "Tolerance and Autoimmunity" being held February 21-26 in Taos, New Mexico. Idera is developing IMO-3100 for the treatment of autoimmune diseases. The presentation entitled "IMO-3100, a novel antagonist, suppresses TLR7- and TLR9-mediated immune responses in non-human primates" was made by Idera scientists.
During a recent three-day Asian Vaccine Conference, health experts appealed to countries to add "under-utilised vaccines such as those of pneumococcal, haemophilus influenzae type-b (Hib), and rotavirus" into national immunization programs, the Nation reports.
Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial.
› Verified 6 days ago
Cvs Pharmacy #16472 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 860 Mankato Ave, Winona, Minnesota 55987 Phone: (507) 452-6308 | |
Walgreens #7727 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 750 Mankato Ave, Winona, Minnesota 55987 Phone: (507) 452-4076 | |
Hy-vee Pharmacy (1896) Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1475 W Service Dr, Winona, Minnesota 55987 Phone: (507) 452-5254 | |
Wal Mart Pharmacy 10-5397 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 955 Frontenac Dr, Winona, Minnesota 55987 Phone: (507) 452-0615 | |
Winona Health Services Clinic Pharm Type: Specialty Pharmacy Location: 859 Mankato Ave, Winona, Minnesota 55987 Phone: (507) 457-7688 |